118 results on '"break-up time (BUT)"'
Search Results
2. FAST® questionnaire for identifying glaucoma patients at risk for ocular surface disease.
3. Outcomes of conjunctivochalasis treatment after fornix deepening with retractor recession and repositioning.
4. Effects of full-thickness wedge resection on ocular surface and in vivo confocal microscopy findings in floppy eyelid syndrome patients.
5. Increased expression of neutrophil CD15 correlates with the severity of anterior ocular surface damage in type II diabetes mellitus.
6. Effectiveness of hyaluronic acid and arnica extract ophthalmic solution in reducing dry eye symptoms in pediatric population.
7. Combined superficial keratectomy, alcohol delamination and amniotic membrane patch with fibrin glue in Salzmann nodular degeneration.
8. Dry eye in mind: Exploring the relationship between sleep and ocular surface diseases.
9. Homoeopathic eye drops in the treatment of mild-to-moderate dry eye disease: Randomised, prospective, multicentre, single-masked study.
10. Analysis of tear film in cystinosis patients treated with topical viscous cysteamine hydrochloride (Cystadrops ®).
11. 34th Meeting of the European Association for Diabetic Eye Complications (EAsDEC) University of Milan, Milan, Italy 30 th May – 1 st June 2024.
12. Liposomal ozonated oil effectiveness in the signs and symptoms of blepharitis in usual clinical practice.
13. Topical insulin, a novel corneal epithelial regeneration agent in dry eye disease.
14. Efficacy and safety of intense pulsed light of upper and lower eyelids in Meibomian gland dysfunction: A prospective multicentric study.
15. Improvement of objective ocular redness measured with Keratograph 5M in glaucoma patients after instilling brimonidine drops.
16. Resolution of Macular Edema secondary to rituximab after intravitreal dexamethasone: A case report and a review of the literature.
17. Ophthalmologic manifestations of adult patients with cystic fibrosis.
18. Cationic nanoemulsion vs. 0.15% sodium hyaluronate artificial tears in the healing process following modern surface keratorefractive surgery.
19. Ocular factors predicting requirement for corneal protective oculoplastic surgery.
20. Morphological and functional assessment of the tear film and meibomian glands in keratoconus.
21. Effects of topical antiglaucomatous medications on central corneal epithelial thickness by anterior segment optical coherence tomography.
22. The effect of tea tree oil on dry eye treatment after phacoemulsification cataract surgery: A randomized clinical trial.
23. Intense regulated pulse light for the meibomian gland dysfunction.
24. Differences in retinal images quality between normal and subclinical keratoconus and its association to posterior corneal asymmetry.
25. Clinical feasibility of pinhole glasses in presbyopia.
26. Ocular surface and in vivo confocal microscopic findings in patients with active tyhroid eye disease treated with glucocorticoids.
27. Management of inflammation in dry eye disease: Recommendations from a European panel of experts.
28. Ocular surface disease signs and symptoms of glaucoma patients and their relation to glaucoma medication in Finland.
29. Changes of symptomatology, tear film and ocular surface integrity one week during Somofilcon-A and Omafilcon-A lens wear.
30. Evaluation of warm compresses and topical cyclosporine treatment in meibomian gland dysfunction by confocal scanning laser microscopy.
31. Combined intense pulsed light and low-level light therapy for the treatment of refractory Meibomian gland dysfunction.
32. Evaluation of tear parameters and meibomian gland morphology in keratoconus patients after epithelial-on corneal cross-linking.
33. Evaluating the topographical measurements and tear function status in patients with hemifacial spasm: A comparative fellow eye study.
34. Effect of facemasks on the tear film during the COVID-19 pandemic.
35. Effect of face mask on topographic corneal parameters in healthy individuals.
36. Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease.
37. Dry eye in Sjögren's syndrome – characteristics and therapy.
38. Dry eye disease, a prominent manifestation of systemic autoimmune disorders.
39. Safety of collagen cross linking in advanced keratoconus in a patient with scleroderma.
40. Comparison between the change in total corneal astigmatism and actual change in refractive astigmatism in transepithelial photorefractive keratectomy (tPRK), laser in situ keratomileusis (LASIK) and femtosecond laser assisted laser in situ keratomileusis (FsLASIK)
41. Assessment of temporal and spatial distribution patterns of aerosol produced by air-puff non-contact tonometer.
42. Clinical evaluation of an oil-based lubricant eyedrop in dry eye patients with lipid deficiency.
43. Dry eye disease and psychiatric disorders: A systematic review and meta-analysis.
44. Is there a role for tapered topical dose steroidal treatment for dry eye disease? A randomized, pilot study.
45. Longitudinal assessment of meibomian glands and tear film layer in systemic isotretinoin treatment.
46. Contrast sensitivity assessment for early detection of hydroxychloroquine toxicity.
47. Impression cytology and meibomian glands in conjunctivochalasis.
48. The study of dry eye and meibomian glands in psoriasis.
49. Dry eye and Meibomian gland dysfunction evaluation in sarcoidosis patients.
50. Ocular surface changes in patients treated with oral antidiabetic drugs or insulin.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.